Chen Hu

690 total citations
39 papers, 365 citations indexed

About

Chen Hu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Chen Hu has authored 39 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Chen Hu's work include Lung Cancer Treatments and Mutations (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Hip and Femur Fractures (3 papers). Chen Hu is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Hip and Femur Fractures (3 papers). Chen Hu collaborates with scholars based in China, United States and Sweden. Chen Hu's co-authors include Yong He, Conghua Lu, Caiyu Lin, Yubo Wang, Li Li, Rui Han, Mingxia Feng, Kejun Zhang, Dadong Zhang and Haiyan Wu and has published in prestigious journals such as Biosensors and Bioelectronics, Carcinogenesis and Anesthesia & Analgesia.

In The Last Decade

Chen Hu

34 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen Hu China 10 153 120 94 89 60 39 365
Alessio Degiovanni Italy 12 121 0.8× 85 0.7× 44 0.5× 107 1.2× 53 0.9× 23 345
Christopher A. Febres‐Aldana United States 10 110 0.7× 75 0.6× 68 0.7× 88 1.0× 44 0.7× 45 327
Pengcheng Luo China 12 152 1.0× 82 0.7× 49 0.5× 70 0.8× 37 0.6× 26 351
Guangjun Shi China 11 187 1.2× 82 0.7× 90 1.0× 74 0.8× 53 0.9× 33 361
Juyong Liang China 10 195 1.3× 74 0.6× 71 0.8× 110 1.2× 36 0.6× 17 371
Yinshan Fang United States 11 182 1.2× 191 1.6× 39 0.4× 46 0.5× 43 0.7× 23 473
Minshan Chen China 10 109 0.7× 55 0.5× 125 1.3× 82 0.9× 121 2.0× 37 480
Yue He China 13 168 1.1× 58 0.5× 101 1.1× 102 1.1× 84 1.4× 49 413
Chunting Tan China 12 195 1.3× 160 1.3× 64 0.7× 31 0.3× 49 0.8× 22 470

Countries citing papers authored by Chen Hu

Since Specialization
Citations

This map shows the geographic impact of Chen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Hu more than expected).

Fields of papers citing papers by Chen Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Hu. The network helps show where Chen Hu may publish in the future.

Co-authorship network of co-authors of Chen Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chen Hu. A scholar is included among the top collaborators of Chen Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen Hu. Chen Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Yihui, Rui Han, Jie Zheng, et al.. (2025). Multieffect Specific Nanovesicles for Homing Resistant Tumors and Overcoming Osimertinib‐Acquired Resistance in NSCLC. Advanced Healthcare Materials. 14(9). e2404087–e2404087. 2 indexed citations
3.
Wu, Ping, et al.. (2025). Smart bandages for wound monitoring and treatment. Biosensors and Bioelectronics. 283. 117522–117522. 5 indexed citations
4.
Lu, Conghua, Chen Hu, Yihui Liu, et al.. (2024). Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect. Journal for ImmunoTherapy of Cancer. 12(6). e009165–e009165. 9 indexed citations
5.
Han, Rui, Caiyu Lin, Conghua Lu, et al.. (2024). Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer. Cancer Letters. 588. 216762–216762. 14 indexed citations
6.
Han, Rui, Caiyu Lin, Chong Zhang, et al.. (2023). The potential therapeutic regimen for overcoming resistance to osimertinib due to rare mutations in NSCLC. iScience. 26(7). 107105–107105. 4 indexed citations
7.
Zhang, Jian, Jie Dai, Zhulin Liu, et al.. (2022). First-Line Osimertinib in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Effectiveness, Resistance Mechanisms, and Prognosis of Different Subsequent Treatments. Clinical Medicine Insights Oncology. 16. 1363255695–1363255695. 6 indexed citations
8.
Li, Li, Zhujun Li, Conghua Lu, et al.. (2022). Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling. Communications Biology. 5(1). 155–155. 26 indexed citations
9.
Zhou, Haodong, Kejun Zhang, Lan Liu, et al.. (2022). Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis. Thoracic Cancer. 13(18). 2574–2583. 5 indexed citations
10.
Chen, Hengyi, Conghua Lu, Caiyu Lin, et al.. (2021). VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy. Carcinogenesis. 42(6). 880–890. 9 indexed citations
11.
Wang, Yubo, Caiyu Lin, Rui Han, et al.. (2020). Metformin attenuates TGF-β1-induced pulmonary fibrosis through inhibition of transglutaminase 2 and subsequent TGF-β pathways. 3 Biotech. 10(6). 287–287. 12 indexed citations
12.
Han, Rui, Shuai Hao, Conghua Lu, et al.. (2020). Aspirin sensitizes osimertinib‐resistant NSCLC cells in vitro and in vivo via Bim‐dependent apoptosis induction. Molecular Oncology. 14(6). 1152–1169. 26 indexed citations
13.
Huang, Hui, Niu Liu, Yi Wang, et al.. (2020). Correlation of Cerebral White Matter Lesions with Carotid Intraplaque Neovascularization assessed by Contrast-enhanced Ultrasound. Journal of Stroke and Cerebrovascular Diseases. 29(8). 104928–104928. 6 indexed citations
14.
Lu, Conghua, et al.. (2019). P2.14-25 Lorlatinib Induced Protective Autophagy via the AKT–mTOR Pathway in ALK- Rearrangement Lung Cancer Cells. Journal of Thoracic Oncology. 14(10). S838–S839. 1 indexed citations
15.
Li, Li, Yubo Wang, Lin Jiao, et al.. (2019). Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer. Cancer Letters. 452. 191–202. 54 indexed citations
17.
Hu, Chen. (2015). Clinical effect of mycophenolate mofetil and tripterygium glycosides on refractory nephrotic syndrome and the influence of renal function. 1 indexed citations
18.
Hu, Chen, et al.. (2015). Association Between Polymorphisms of DRD2, COMT, DBH, and MAO-A Genes and Migraine Susceptibility. Medicine. 94(47). e2012–e2012. 9 indexed citations
19.
Zhuang, Li, Xiangyan Liu, Chen Hu, et al.. (2014). Pulmonary lymphangitic carcinomatosis in liver carcinoma: a rare case report and literature review. World Journal of Surgical Oncology. 12(1). 66–66. 8 indexed citations
20.
Chen, S, Qi Han, Mingzhen Yang, et al.. (2013). IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway. Cell Death and Disease. 4(10). e842–e842. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026